After nearly a decade of work, Akili Interactive received the green light from the FDA to market its video game as a treatment for ADHD. It wasn’t an easy feat, and the company still has a long road ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, today announced that its Founded Entity, Akili ...

Akili Interactive (“Akili”), a leading digital medicine company, today announced the EndeavorRx ® Expedition product registry, which aims to obtain feedback from patients receiving the digital ...

After years of waiting, Akili Interactive has finally received FDA De Novo marketing authorization for EndeavorRx, its video-game digital therapeutic for children aged 8 to 12 years with ADHD. This is ...

Akili Interactive has published the full data from its STARS-ADHD Adjunctive trial. The data builds upon the company's pivotal study of AKL-T01 (now available as EndeavorRx) and suggests the videogame ...

BOSTON--(BUSINESS WIRE)--Akili Interactive (“Akili”), a leading prescription digital therapeutics company, today announced that EndeavorRx®, the first and only prescription video game treatment for ...

Attention improvements were nearly three times as large as those in the pivotal trial that served as the basis for EndeavorRx’s FDA authorization for children with ADHD ages 8-12 Study data will be ...

A prescription-only video game called EndeavorRx that treats kids with ADHD has been approved by the FDA. The game is aimed at children between the ages of eight and 12 who suffer with certain types ...

A new video game called EndeavorRX has become the first video game that can legally be marketed and prescribed as medication in the United States. It's been made by a company called Akili Interactive, ...